Despite MannKind (MNKD) reporting third-quarter revenue for diabetes drug Afrezza below H.C.
Yesterday, United Therapeutics (UTHR), MannKind’s (MNKD) partner for Technosphere treprostinil (TreT), hosted its Science Day 2018. MannKind’s dry powder inhalable treprostinil formulation for …
This week, MannKind (MNKD) announced a global partnership with United Therapeutics (UTHR) to develop and commercialize Technosphere treprostinil (TreT) dry powder inhalation for …
H.C.
Shares of biotechnology company MannKind (NASDAQ:MNKD) are taking a hit – down nearly 25% as of this writing. The reason?
What do you do when a company has “more debt than assets?” Maxim’s Jason Kolbert just lost patience with MNKD.
MannKind Corporation (NASDAQ:MNKD), a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes, today announced the appointment of …
As MannKind spends precious cash, it moves closer to the next capital raise (a.k.
